BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29693784)

  • 1. Meta-analysis of the incidence and patterns of second neoplasms after photon craniospinal irradiation in children with medulloblastoma.
    Bavle A; Tewari S; Sisson A; Chintagumpala M; Anderson M; Paulino AC
    Pediatr Blood Cancer; 2018 Aug; 65(8):e27095. PubMed ID: 29693784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study on the risks of radiogenic second cancers and cardiac mortality in a set of pediatric medulloblastoma patients treated with photon or proton craniospinal irradiation.
    Zhang R; Howell RM; Taddei PJ; Giebeler A; Mahajan A; Newhauser WD
    Radiother Oncol; 2014 Oct; 113(1):84-8. PubMed ID: 25128084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of dosimetric and toxicity modeling of proton versus photon craniospinal irradiation for pediatrics medulloblastoma.
    Ho ESQ; Barrett SA; Mullaney LM
    Acta Oncol; 2017 Aug; 56(8):1031-1042. PubMed ID: 28509599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late toxicity following craniospinal radiation for early-stage medulloblastoma.
    Christopherson KM; Rotondo RL; Bradley JA; Pincus DW; Wynn TT; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
    Acta Oncol; 2014 Apr; 53(4):471-80. PubMed ID: 24564687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of risk of radiogenic second cancer following photon and proton craniospinal irradiation for a pediatric medulloblastoma patient.
    Zhang R; Howell RM; Giebeler A; Taddei PJ; Mahajan A; Newhauser WD
    Phys Med Biol; 2013 Feb; 58(4):807-23. PubMed ID: 23322160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vulnerability of white matter to insult during childhood: evidence from patients treated for medulloblastoma.
    Moxon-Emre I; Bouffet E; Taylor MD; Laperriere N; Sharpe MB; Laughlin S; Bartels U; Scantlebury N; Law N; Malkin D; Skocic J; Richard L; Mabbott DJ
    J Neurosurg Pediatr; 2016 Jul; 18(1):29-40. PubMed ID: 27015518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of failure after proton therapy in medulloblastoma; linear energy transfer distributions and relative biological effectiveness associations for relapses.
    Sethi RV; Giantsoudi D; Raiford M; Malhi I; Niemierko A; Rapalino O; Caruso P; Yock TI; Tarbell NJ; Paganetti H; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):655-63. PubMed ID: 24521681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of permanent alopecia in pediatric medulloblastoma patients treated with proton radiation.
    Min CH; Paganetti H; Winey BA; Adams J; MacDonald SM; Tarbell NJ; Yock TI
    Radiat Oncol; 2014 Nov; 9():220. PubMed ID: 25403752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Outcomes Among Children With Standard-Risk Medulloblastoma Treated With Proton and Photon Radiation Therapy: A Comparison of Disease Control and Overall Survival.
    Eaton BR; Esiashvili N; Kim S; Weyman EA; Thornton LT; Mazewski C; MacDonald T; Ebb D; MacDonald SM; Tarbell NJ; Yock TI
    Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):133-138. PubMed ID: 26700707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian function in survivors of childhood medulloblastoma: Impact of reduced dose craniospinal irradiation and high-dose chemotherapy with autologous stem cell rescue.
    Balachandar S; Dunkel IJ; Khakoo Y; Wolden S; Allen J; Sklar CA
    Pediatr Blood Cancer; 2015 Feb; 62(2):317-321. PubMed ID: 25346052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of CNS Injury for a Cohort of 111 Patients Treated With Proton Therapy for Medulloblastoma: LET and RBE Associations for Areas of Injury.
    Giantsoudi D; Sethi RV; Yeap BY; Eaton BR; Ebb DH; Caruso PA; Rapalino O; Chen YE; Adams JA; Yock TI; Tarbell NJ; Paganetti H; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):287-296. PubMed ID: 26691786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing the radiation therapy dose prescription for pediatric medulloblastoma: minimizing the life years lost attributable to failure to control the disease and late complication risk.
    Brodin NP; Vogelius IR; Björk-Eriksson T; Munck Af Rosenschöld P; Maraldo MV; Aznar MC; Specht L; Bentzen SM
    Acta Oncol; 2014 Apr; 53(4):462-70. PubMed ID: 24274390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subsequent neoplasms in survivors of childhood central nervous system tumors: risk after modern multimodal therapy.
    Tsui K; Gajjar A; Li C; Srivastava D; Broniscer A; Wetmore C; Kun LE; Merchant TE; Ellison DW; Orr BA; Boop FA; Klimo P; Ross J; Robison LL; Armstrong GT
    Neuro Oncol; 2015 Mar; 17(3):448-56. PubMed ID: 25395462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study.
    Yock TI; Yeap BY; Ebb DH; Weyman E; Eaton BR; Sherry NA; Jones RM; MacDonald SM; Pulsifer MB; Lavally B; Abrams AN; Huang MS; Marcus KJ; Tarbell NJ
    Lancet Oncol; 2016 Mar; 17(3):287-298. PubMed ID: 26830377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative incidence of radiation-induced cavernomas in long-term survivors of medulloblastoma.
    Lew SM; Morgan JN; Psaty E; Lefton DR; Allen JC; Abbott R
    J Neurosurg; 2006 Feb; 104(2 Suppl):103-7. PubMed ID: 16506497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric CSI: are protons the only ethical approach?
    Johnstone PA; McMullen KP; Buchsbaum JC; Douglas JG; Helft P
    Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):228-30. PubMed ID: 23958143
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of therapeutic dosimetric data from passively scattered proton and photon craniospinal irradiations for medulloblastoma.
    Howell RM; Giebeler A; Koontz-Raisig W; Mahajan A; Etzel CJ; D'Amelio AM; Homann KL; Newhauser WD
    Radiat Oncol; 2012 Jul; 7():116. PubMed ID: 22828073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical combinations of radiation dose and volume predict intelligence quotient and academic achievement scores after craniospinal irradiation in children with medulloblastoma.
    Merchant TE; Schreiber JE; Wu S; Lukose R; Xiong X; Gajjar A
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):554-61. PubMed ID: 25160611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute toxicity profile of craniospinal irradiation with intensity-modulated radiation therapy in children with medulloblastoma: A prospective analysis.
    Cox MC; Kusters JM; Gidding CE; Schieving JH; van Lindert EJ; Kaanders JH; Janssens GO
    Radiat Oncol; 2015 Nov; 10():241. PubMed ID: 26597178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating Intensity Modulated Proton Therapy Relative to Passive Scattering Proton Therapy for Increased Vertebral Column Sparing in Craniospinal Irradiation in Growing Pediatric Patients.
    Giantsoudi D; Seco J; Eaton BR; Simeone FJ; Kooy H; Yock TI; Tarbell NJ; DeLaney TF; Adams J; Paganetti H; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):37-46. PubMed ID: 28587051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.